0

Close
 
2016
STD Reimbursement Scenario Analysis And Top Std Testing Technologies

STD Reimbursement Scenario Analysis And Top Std Testing Technologies (Pcr, Immunochromatographic Capillary Flow Dipstick Technology, Flow Cytometry, Differential Light Scattering, Enzyme Linked Immunosorbent Assay, Rapid Diagnostic Kits, Phone Chips, Microfluidics, And Immunochromatographic Tests) - Global Opportunity Analysis And Industry Forecast, 2014 - 2022 Market

Update Available On-Demand

LS : Medical Devices & Supplies
Report Code: A01447
Dec 2016 | Pages: 32
Tables: 15
Charts: 9.

  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.
 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the STD Reimbursement Scenario Analysis And Top Std Testing Technologies

Request Now !

The global sexually transmitted diseases (STDs) testing market size was valued at $107,024 million in 2015, and is projected to reach $190,010 million by 2022, registering a CAGR of 8.5% over the forecast period. High incidences of STDs and increased governmental support are the factors that drive the market growth. In addition, rise in awareness among people, and patient education are the other pivotal factors that fuel the growth of the market.
Sexually transmitted diseases (STDs) are infections that are transmitted from one person to another through sexual contact. STDs affect individuals of all ages, however, according to CDC, age group of 15–24 accounts for half of all new STDs infections. Currently, STDs are the most common diseases in U.S., and as per CDC, about 19 million men and women are diagnosed with STDs each year. The disease is caused due to transmission of microbes (bacteria, virus, yeast, and parasites) during sexual intercourse. The disease is diagnosed using laboratory and point-of-care tests such as differential light scattering, ELISA, micro fluidics, and immunochromatographic test (ICTs).
STD Reimbursement Market
 
Favorable reimbursement scenario for STD tests in the U.S. market is set to further drive the market growth. This report provides deep understanding of the laboratory claims for STD tests in the U.S. Claims for laboratory services must include an ICD-10-CM codes, which are found in the “ICD-10-CM Diagnosis Code” column of the laboratory services grid. For several laboratory tests, only ICD-10-CM codes are required for reimbursement. Some of the laboratory tests also require an additional code for reimbursement, which provides the medical necessity to perform tests. Since 2011, CMS covers screening for chlamydia, gonorrhea, syphilis, HIV, and HPV with the appropriate FDA-approved lab tests used with FDA-approved labeling and in compliance with CLIA regulations when ordered by a primary care provider, and performed by an eligible Medicare provider for these services.
However, stigma related to voluntary testing and critical regulatory compliance forms are the restraints for the market. However, global initiatives along with development in healthcare infrastructure are projected to provide platform for the market growth.
 
GLOBAL SEXUALLY TRANSMITTED DISEASES (STDS) TESTING MARKET SEGMENTATION, BY TECHNOLOGY
Flow cytometry sexually transmitted diseases testing market overview
Segment Review
STDs testing market is segmented into laboratory and point-of-care testing devices. Based on laboratory testing devices, the market is divided into PCR, immunochromatographic capillary flow dipstick technology (assays), flow cytometry, differential light scattering, and enzyme-linked immunosorbent assay (ELISA). On the basis of point-of-care testing devices, the market is further segmented into rapid diagnostic kits, phone chips, microfluidics, and immunochromatographic tests. Currently, laboratories perform bulk of the tests, and are anticipated to continue to hold larger share of the market, both in terms of volume and revenue.
Flow cytometry is expected to grow fastest, owing to its cost-effectiveness and accuracy of these tests for the diagnosis of STDs in laboratories. However, trained personnel and expensive equipment are required for using this technology, which can be a prime cause of concern.
 
Flow Cytometry: Sexually Transmitted Diseases (STDs) Testing Market Overview ($Million), 2016-2022 
Global sexually transmitted diseases testing market segmentation by technology
KEY BENEFITS FOR STAKEHOLDERS
  • The report provides an in-depth analysis of the market along with current trends and future estimations to elucidate the imminent investment pockets.
  • The report provides a quantitative analysis for the period of 2014–2022 to enable stakeholders to capitalize on the prevailing market opportunities.
  • Extensive analysis of the market based on technology helps to understand the type of devices used to treat STDs.
  • Extensive analysis of the market is conducted by following key technology positioning and by monitoring the top contenders within the market framework.
KEY MARKET SEGMENTS
 
By Technology
 
Laboratory Testing Devices
  • Polymerase chain reaction (PCR)
  • Immunochromatographic capillary flow dipstick technology (assay)
  • Flow cytometry
  • Differential light scattering
  • Enzyme-linked immunosorbent assay (ELISA)
Point-Of-Care (POC) Testing Devices
  • Phone chips
  • Microfluidics
  • Immunochromatographic tests (ICTs)
  • Rapid diagnostic kits

 STD Reimbursement Scenario Analysis And Top Std Testing Technologies Report Highlights

Aspects Details
By TECHNOLOGY
  • LABORATORY TESTING DEVICES
    • Polymerase chain reaction (PCR)
    • Immunochromatographic capillary flow dipstick technology (Assay)
    • Flow cytometry
    • Differential light scattering
    • Enzyme linked immunosorbent assay (ELISA)
  • POINT-OF-CARE (POC) TESTING DEVICES
    • Phone Chips
    • Microfluidics
    • Immunochromatographic tests (ICTs)
    • Rapid diagnostic kits
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, Italy, Spain, UK, Russia, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Thailand, Malaysia, Indonesia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, UAE, Argentina, Rest of LAMEA)
 

CHAPTER 1. INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY MARKET SEGMENTS
1.3. RESEARCH METHODOLOGY

1.3.1. Secondary research
1.3.2. Primary research
1.3.3. Analyst tools and models

CHAPTER 2. EXECUTIVE SUMMARY

CHAPTER 3. REIMBURSEMENT SCENARIO

3.1. OVERVIEW
3.2. PREVENTIVE SERVICE BILLING AND CODING REFERENCE

CHAPTER 4. GLOBAL STD TESTING MARKET, BY TECHNOLOGY

4.1. INTRODUCTION

4.1.1. Market size and forecast

4.2. LABORATORY TESTING DEVICES

4.2.1. Polymerase chain reaction (PCR)

4.2.1.1. Market size and forecast

4.2.2. Immunochromatographic capillary flow dipstick technology (Assay)

4.2.2.1. Market size and forecast

4.2.3. Flow cytometry

4.2.3.1. Market size and forecast

4.2.4. Differential light scattering

4.2.4.1. Market size and forecast

4.2.5. Enzyme linked immunosorbent assay (ELISA)

4.2.5.1. Market size and forecast

5.3. POINT-OF-CARE (POC) TESTING DEVICES

5.3.1. Phone Chips

5.3.1.1. Market size and forecast

5.3.2. Microfluidics

5.3.2.1. Market size and forecast

5.3.3. Immunochromatographic tests (ICTs)

5.3.3.1. Market size and forecast

5.3.4. Rapid diagnostic kits

5.3.4.1. Market size and forecast

List of Tables

TABLE 1. STD PREVENTIVE SERVICES BY CDC
TABLE 2. LIST OF HCPCS/CPT CODES AND ICD-10 DIAGNOSIS CODE
TABLE 3. GLOBAL STD TESTING MARKET, BY LOCATION OF TESTING, 2014-2022 ($MILLION)
TABLE 4. GLOBAL STD TESTING MARKET, BY TECHNOLOGY, 2014-2022 ($MILLION)
TABLE 5. WORLD STD TESTING MARKET FOR PCR, 2014-2022 ($MILLION)
TABLE 6. WORLD STD TESTING MARKET FOR IMMUNOCHROMATOGRAPHIC CAPILLARY FLOW DIPSTICK, 2014-2022 ($MILLION)
TABLE 7. WORLD STD TESTING MARKET FOR FLOW CYTOMETRY, 2014-2022 ($MILLION)
TABLE 8. WORLD STD TESTING MARKET FOR DIFFERENTIAL LIGHT SCATTERING, 2014-2022 ($MILLION)
TABLE 9. WORLD STD TESTING MARKET FOR ELISA, 2014-2022 ($MILLION)
TABLE 10. TESTING TECHNOLOGIES FOR STDS
TABLE 11. WORLD STD TESTING MARKET FOR PHONE CHIPS, 2014-2022 ($MILLION)
TABLE 12. WORLD STD TESTING MARKET FOR MICROFLUIDICS, 2014-2022 ($MILLION)
TABLE 13. WORLD STD TESTING MARKET FOR IMMUNOCHROMATOGRAPHIC TEST, 2014-2022 ($MILLION)
TABLE 14. SEROLOGICAL TEST FOR STDS
TABLE 15. WORLD STD TESTING MARKET FOR RAPID DIAGNOSTIC KITS, 2014-2022 ($MILLION)

List of Figures

FIGURE 1. WORLD STD TESTING MARKET FOR PCR, 2014-2022 ($MILLION)
FIGURE 2. WORLD STD TESTING MARKET FOR IMMUNOCHROMATOGRAPHIC CAPILLARY FLOW DIPSTICK, 2014-2022 ($MILLION)
FIGURE 3. WORLD STD TESTING MARKET FOR IMMUNOCHROMATOGRAPHIC CAPILLARY FLOW DIPSTICK, 2014-2022 ($MILLION)
FIGURE 4. WORLD STD TESTING MARKET FOR DIFFERENTIAL LIGHT SCATTERING, 2014-2022 ($MILLION)
FIGURE 5. WORLD STD TESTING MARKET FOR ELISA, 2014-2022 ($MILLION)
FIGURE 6. WORLD STD TESTING MARKET FOR PHONE CHIPS, 2014-2022 ($MILLION)
FIGURE 7. WORLD STD TESTING MARKET FOR MICROFLUIDICS, 2014-2022 ($MILLION)
FIGURE 8. WORLD STD TESTING MARKET FOR IMMUNOCHROMATOGRAPHIC TEST, 2014-2022 ($MILLION)
FIGURE 9. WORLD STD TESTING MARKET FOR RAPID DIAGNOSTIC KITS, 2014-2022 ($MILLION)


 
 

The sexually transmitted diseases (STDs) testing market is growing at a remarkable pace globally, owing to rise in incidences of fatal STDs, increased implementation of service provider-initiated counseling and testing (PICT) & client-initiated counseling and testing (CICT), and development of novel technologies such as microfluidics and rapid diagnostics kits to test HIV at home. With the rise in prevalence of STDs, the diagnosis of the disease is also increasing. For instance, as per CDC, about 20 million new STD cases are diagnosed each year. The diagnosis of STDs is facilitated through laboratory and point-of-care testing devices.

Polymerase chain reaction (PCR) segment dominated the overall market with a share of more than half of the overall market in 2015, and is projected to continue to lead the market during the forecast period. This is attributed to effective detection offered by this technology and high adoption in developed economies. Moreover, flow cytometry is expected to grow fastest after microfluidics, owing to its cost-effectiveness and accuracy for the diagnosis of STDs in laboratories. However, trained personnel and expensive equipment are required to use these devices, which can be a prime cause of concern.

Favorable reimbursement policies for STD tests plays a vital role in the growth of the U.S. market. The tests that are used in the diagnosis of STDs (such as chlamydia, syphilis, gonorrhea, herpes simplex, human papilloma virus, and HIV) are reimbursed in the U.S. by the Centers for Medicare & Medicaid Services (CMS) through different CPT codes (as per ICD-10 that was implemented in October 2015). However, the tests for the diagnosis of chancroid are not covered by the CMS due to the unavailability of FDA-approved diagnostic tests for this disease in the U.S., as very few people are diagnosed in the country each year. Moreover, it is studied that most of the individuals in the U.S. who are diagnosed with this infection have traveled outside the country to areas where chancroid is more common.

PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Request Sample
RELATED TAGS

Purchase Full Report of
STD Reimbursement Scenario Analysis And Top Std Testing Technologies

Start reading instantly.
This Report and over 67,068+ more Reports, Available with Avenue Library. T&C*.

  • Data Pack
  • $1,788
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Dec 2017 - Dec 2018)
  • Single User
  • $2,500
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Dec 2017 - Dec 2018)
  • Five Users
  • $3,003
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Dec 2017 - Dec 2018)

  • Enterprise
    License/PDF

  • $5,188
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Dec 2017 - Dec 2018)

  • Library
    Membership

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

RELATED REPORTS
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers